Core Viewpoint - Yongsheng Medical (01612) experienced a stock price increase of over 9% following a profit alert, with shares trading at HKD 0.94 and a transaction volume of HKD 5.3888 million [1] Financial Performance - The company anticipates an unaudited consolidated profit attributable to shareholders of no less than HKD 100 million for the fiscal year ending December 31, 2025 [1] - For the fiscal year ending December 31, 2024, the audited profit attributable to shareholders is expected to be approximately HKD 69.2 million [1] Business Drivers - The significant increase in revenue is attributed to strengthened relationships with a major customer in the imaging disposable products segment and the expansion of business scale [1] - The company has achieved better economies of scale by enhancing capacity utilization and operational efficiency, leading to improved gross margins [1]
港股异动 | 永胜医疗(01612)盈喜后涨超9% 预期25年度股东应占综合溢利不少于1亿港元